Summit Therapeutics

Interactive Chart

News & Analysis: Summit Therapeutics

Todd Campbell | Feb 6, 2018

The company rewarded investors with some good news last month.

Todd Campbell | Jan 25, 2018

Could the company's lead drug candidate eventually become standard care in Duchenne muscular dystrophy?

Todd Campbell | Feb 6, 2018

The company rewarded investors with some good news last month.

Todd Campbell | Jan 25, 2018

Could the company's lead drug candidate eventually become standard care in Duchenne muscular dystrophy?

Key Data Points

Primary metrics and data points about Summit Therapeutics.

Current Price:

Business Summary

None

Sector: Health Care
Industry: Biotechnology

One Broadway 14th Floor
Cambridge, MA 02142
United States
www.summitplc.com